Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...

A brain tumor is a mass of abnormal cells that grow in the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous) and can start anywhere in the brain. Malignant tumors grow rapidly ...

1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill ...

Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria Background: The G protein-coupled receptor 55 (GPR55) is part of an expanded endocannabinoid system (ECS ...

Pancreatic cancer five-year relative survival: 12.8% Pancreatic cancer has a 12.8% five-year survival rate. It can be effectively treated if detected early, but when diagnosed at more advanced ...

T-cell engagers are a class of immunotherapies that direct T cells to recognise and eliminate cancer cells. Credit: skynesher via Getty Images. US-based Normunity has raised $75m in a Series B funding ...

Pancreatic cancer, one of the most formidable, could soon see its treatment transformed. Researchers have identified an enzyme, Mical2, which plays a central role in the progression of this disease.

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...

GRAND RAPIDS, Mich. (Jan. 13, 2025) — An experimental blood test for pancreatic cancer that was developed by Van Andel Institute and University of Pittsburgh scientists is being evaluated by a ...

Background: To estimate the global burden of pancreatic cancer in 2019 and 2021 including incidence, mortality, and disability-adjusted-life-years (DALYs). Methods: Data on pancreatic cancer incidence ...